Protagenic Therapeutics(DE:MBP0)
€1.590.00 (0.00%)
DE:MBP0
Protagenic Therapeutics ownership
€1.59
At close:0.00 (0.00%)
Protagenic Therapeutics (MBP0) Ownership - Who Owns Protagenic Therapeutics?
0 Followers
Protagenic Therapeutics (MBP0) Ownership Overview
- 4.06% Insiders
- 1.38% Other Institutional Investors
- 94.56% Public Companies and Individual Investors
The ownership structure of Protagenic Therapeutics (DE:MBP0) stock is a mix of institutional, retail, and individual investors. Approximately 1.38% of the company’s stock is owned by Institutional Investors, 4.06% is owned by Insiders, and 94.56% is owned by Public Companies and Individual Investors.
The ownership structure of Protagenic Therapeutics (DE:MBP0) stock is a mix of institutional, retail, and individual investors. Approximately 1.38% of the company’s stock is owned by Institutional Investors, 4.06% is owned by Insiders, and 94.56% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 23, 2026 | Garo Armen | $13,000 | |
| Aug 19, 2026 | Garo Armen | $945 | |
| Aug 19, 2026 | Garo Armen | $9,648 | |
| Aug 11, 2026 | Garo Armen | $710 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Garo Armen | 73,533 | Insider | 4.06% | 129,565 |
FAQ
Who Owns Protagenic Therapeutics (DE:MBP0)?
According to the latest TipRanks data, approximately 1.38% of the company's stock is held by institutional investors, 4.06% is held by insiders, and 94.56% is held by public companies and individual investors.
What percentage of Protagenic Therapeutics (DE:MBP0) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.38% of Protagenic Therapeutics (DE:MBP0) stock is held by institutional investors.
What percentage of Protagenic Therapeutics (DE:MBP0) stock is held by retail investors?
According to the latest TipRanks data, approximately 94.56% of Protagenic Therapeutics (DE:MBP0) stock is held by public companies and individual investors.
Who owns the most shares of Protagenic Therapeutics (DE:MBP0)?
Garo Armen owns the most shares of Protagenic Therapeutics (DE:MBP0).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
